Hello

Your subscription is almost coming to an end. Don’t miss out on the great content on Nation.Africa

Ready to continue your informative journey with us?

Hello

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and in-depth features.

Reclaim your full access. Click below to renew.

Subscribe for a month to get full access

Premium

Fingers crossed as Kenya joins search for a cure in drugs tests

test
test

By  Bernadine Mutanu

Health&Environment reporter

Nation Media Group

What you need to know:

  • Recruitment for the clinical trial of remdesivir and tocilizumab (TCZ) is ongoing.
  • An antiviral medicine, it was originally developed to treat Ebola and is administered via injection.
  • Recruitment is expected to end on February 28, 2021 and results are expected to be published by the end of next year.

Kenya is participating in clinical trials for two drugs which, if successful, will be used to treat Covid-19.

The tests are being done at a time when Covid-19 cases have soared in the country and deaths from the disease have begun to rise by double digits.

Related

In the headlines